22 structural-engineering "https:" "https:" "https:" "https:" "https:" "https:" "Multiple" "U.S" research jobs at City of Hope
Sort by
Refine Your Search
-
Institute at City of Hope. You will work on projects related to the molecular mechanisms underlying the aging-related diabetes development using genetically engineered mouse models and multiple omics
-
, shaping the future of medicine through cutting-edge research. A Clinical Research Assistant II role is available under Dr. Richard Lee to support the Cherng Family Center. You will manage a set of multiple
-
disorders. Recent postdoctoral fellows from our lab have successfully transitioned to positions in academia and the pharmaceutical industry, both in the U.S. and internationally. Our work focuses on
-
, Cancer Biology, Chromatin Regulation, Cancer Epigenetics, Epigenetics Regulation, Cancer Metabolism, Immunology, Drug Discovery, Development, and Structural Biology, with an emphasis on RNA epigenetics
-
handle multiple projects simultaneously. Your qualifications should include: · Ph.D., MD, or MD/Ph.D., with a strong background and profound knowledge in oncology, cancer biology, immunology
-
, shaping the future of medicine through cutting-edge research. The Jianjun Chen Lab at City of Hope is looking for talented Postdoctoral Fellows to study cancer and stem cell biology. There are multiple
-
: · Perform collaborative research with multiple faculty members at ARDMRI on projects involving genomics data analysis using single cell RNA-seq, CHIP-seq/ATAC-seq, spatial transcriptomics, HiC/HiCHIP, RIBO
-
presentation, ability to work efficiently in a team and with collaborators · Experience in Single Cell Multi-omics techniques and multiple component analysis programs is an advantage · Previous
-
through cutting-edge research. Exciting opportunity for a detail-oriented individual! Join us as a Clinical Research Assistant I in which you will manage an assigned set of multiple research protocols
-
Institute at City of Hope. You will work on projects investigating the new pathways and targets in diabetes/obesity and cancer. The lab uses genetically engineered mouse models and molecular pharmacology